STOCK TITAN

Baxter Intl Inc Stock Price, News & Analysis

BAX NYSE

Welcome to our dedicated page for Baxter Intl news (Ticker: BAX), a resource for investors and traders seeking the latest updates and insights on Baxter Intl stock.

Baxter International Inc (NYSE: BAX) is a global healthcare leader specializing in life-saving renal care, advanced medical devices, and hospital solutions. This page provides investors and healthcare professionals with timely updates on the company’s operational developments, regulatory milestones, and strategic initiatives.

Access authoritative information about Baxter’s latest financial results, product innovations, and partnerships. Our curated news collection simplifies tracking of critical updates across key areas including dialysis technologies, infusion systems, and biosurgery products.

Discover official announcements regarding:
• Quarterly earnings and financial guidance
• New product approvals and clinical trials
• Strategic acquisitions in medical technology
• Regulatory compliance updates
• Leadership changes and corporate governance

Bookmark this page for streamlined access to Baxter’s verified news developments. Check regularly for updates that may impact market positioning and healthcare sector trends.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.84%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.05%
Tags
conferences earnings
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.85%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.19%
Tags
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.55%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.96%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.68%
Tags
none
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.78%
Tags
dividends
Rhea-AI Summary

Baxter International Inc. (NYSE:BAX) reported first-quarter 2023 revenue of $3.65 billion, a 2% decrease year-over-year on a reported basis but a 2% increase on a constant currency basis. U.S. GAAP earnings per share (EPS) were $0.09, while adjusted EPS was $0.59. For 2023, Baxter anticipates sales growth of 1% to 2% and U.S. GAAP EPS between $1.16 and $1.31, with adjusted EPS between $2.85 and $3.00. Key drivers for sales included Advanced Surgery and Pharmaceuticals, though declines were noted in Acute Therapies and Patient Support Systems. The company is also advancing a strategic spinoff of its Kidney Care segment, expected to occur by July 2024. Innovation efforts include launching the Novum IQ and ExactaMix Pro systems, aimed at enhancing patient care and operational efficiency.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.56%
Tags

FAQ

What is the current stock price of Baxter Intl (BAX)?

The current stock price of Baxter Intl (BAX) is $22.93 as of October 22, 2025.

What is the market cap of Baxter Intl (BAX)?

The market cap of Baxter Intl (BAX) is approximately 11.7B.
Baxter Intl Inc

NYSE:BAX

BAX Rankings

BAX Stock Data

11.68B
511.24M
0.37%
102.36%
4.52%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
DEERFIELD